NCT00413049
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
See it on ClinicalTrials.gov β696 people
34.9%
65.1%
243 womenmiddle line = equal numbers453 men
- Phase
- PHASE3
- Paid for by
- Novartis
- Finished
- 2007-11
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years β 85 Years
- Average age
- mean 53.8 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
βPregnant or nursing (lactating) women, where pregnancy was defined as the state of a female after conception and until the termination of gestation, confirmed by a positive human chorionic gonadotropin (hCG) laboratory test (\> 5 mIU/ml).β
- No breastfeeding moms
Women who were breastfeeding could not join.
βPregnant or nursing (lactating) women, where pregnancy was defined as the state of a female after conception and until the termination of gestation, confirmed by a positive human chorionic gonadotropin (hCG) laboratory test (\> 5 mIU/ml).β
- No hormonal birth control
Women on the pill, patch, ring, shot, implant or hormonal IUD could not join.
ββ¦dy and for 7 days after study drug discontinuation. Periodic abstinence (eg, calendar, ovulation, symptothermal, post-ovulation methods) and withdrawal were not acceptable methods of contraception. Hormonal contraceptive use was disallowed.β
- No kidney or liver problems
Women with kidney or liver problems were turned away.
ββ¦a secondary form of hypertension, including but not limited to any of the following: coarctation of the aorta, hyperaldosteronism, unilateral or bilateral renal artery stenosis, Cushing disease, pheochromocytoma, polycystic kidney disease.β
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
βHistory of hypertensive encephalopathy, cerebrovascular accident or transient ischemic attack, myocardial infarction or all types of revascularization.β
- No diabetes
Women with diabetes were turned away.
βAll patients with Type 1 diabetes mellitus and those patients with Type 2 diabetes mellitus who were not well controlled based on the investigator's clinical judgment. Patients being treated for diabetes mellitus had to have satisfactory meβ¦β
- No cancer
Women with current or past cancer were turned away.
βMalignant hypertension.β
Study titles and rules are shown in their original English.